How the COVID Virus Induces Inflammation, Cytokine Storm and Stress in Infected Lung Cells – SciTechDaily

The coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the human receptor-ACE2 were calculated from several publicly available datasets pertaining to lung epithelial cells infected with SARS-CoV-2. The resulting gene-signature consisted of members from the Trans-Membrane-Serine-Protease (TMPRSS) gene family which prime the virus spike protein for cell entry. Other genes from the gene-signature are associated with reduced immune responses and activated inflammation, Reactive Oxygen Species (ROS) and cellular stress. Credit: WruckW /AdjayeJ, HHU Duesseldorf, Germany

The researchers Wasco Wruck and Prof. James Adjaye from the Institute of Stem Cell Research and Regenerative Medicine, Medical Faculty of Heinrich-Heine-University Duesseldorf, Germany, employed a bioinformatic approach on transcriptome data pertaining to human lung epithelial cells infected with SARS-CoV-2. The meta-analysis unveiled several adversely affected biological processes in the lung which no doubt also applies to other infected organs such as the heart and kidney. Their study is published in Scientific Reports.

With a current estimation of more than 60 Mio. infected people and more than 1.4 Mio. recorded deaths worldwide, COVID-19 the disease caused by the coronavirus SARS-CoV-2 and is classified as a pandemic by the WHO poses a threat to public health, national economies, and society as a whole. Although effective vaccines are becoming available, we still need a better understanding of the molecular mechanisms underlying the etiology of COVID-19 to enable more effective therapies in the future.

Wasco Wruck, first author of the study, says: We initially viewed the results of the analysis in an unbiased manner. To our surprise, we noticed that several Transmembrane Serine Proteases besides the already known TMPRSS2 were highly correlated with ACE2 expression. Furthermore, in a more in-depth analysis, the gene-signature could be annotated with numerous biological processes. Among these were regulation of viral life cycle, immune responses, pro-inflammatory responses, several interleukins such as IL6, IL1, IL20 and IL33, IFI16 regulating the interferon response to a virus, chemo-attraction of macrophages, and cellular stress resulting from activated Reactive Oxygen Species.

Prof. James Adjaye, senior author of the study, summarizes: We have shown that not having access or the necessary infrastructure to carry out research with the deadly coronavirus SARS-CoV-2 should not preclude progress in dissecting the etiology underlying COVID-19. There are currently numerous transcriptome-based datasets related to experiments carried out on numerous cell types infected with SARS-CoV-2 which can be retrieved and analyzed to identify adversely affected biological processes with the hope of identifying putative druggable targets that can be used to better manage COVID-19 in the future.

Reference: SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress by Wasco Wruck and James Adjaye, 8 December 2020, Scientific Reports. DOI: 10.1038/s41598-020-78402-2

More:
How the COVID Virus Induces Inflammation, Cytokine Storm and Stress in Infected Lung Cells - SciTechDaily

Four years after devastating spinal injury, former St. Paul’s football player reunites with caregivers – NOLA.com

Michael Doherty was just 17 when he lost the ability to walk, but the former St. Paul's studenthasn't lost his determination to regain the mobility taken from him when he suffered a spinal cord injury during a 2016 football game at the Covington school.

Now a junior at LSU, Doherty is quick to say that he's gained something in the years since his injurythe realization that nothing should be taken for granted and a deep gratitude for those who've helped him, including doctors, nurses and therapists, as well as family and friends.

During a recent visit to Lakeview Regional Medical Center, the 21-year-old said thank you in person to some of the staff members who cared for him when he arrived at the Covington areahospital's emergency department on that fateful November night, a stay that stretched to 17 days.

Michael Doherty, center, heads to his truck after visiting with the medical team at Lakeview Regional Medical Center near Covington that helped him during surgery and recovery following a spinal injury he suffered while playing high school football in November 2016. Doherty uses a wheelchair to get around but he and his doctors hope he'll be able to walk again in the future. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)

"He could hardly raise his arms," said Holly Leonhard, then a critical care nurse and now a nurse practitioner, as she marveled at her former patient's progress.

This time, Doherty arrived at the hospital on his own steam, driving a modified truck that uses hand controls and a platform that slides out so he can maneuver his wheelchair without assistance.

Many people on his team of caregivers 27 in all had not seen him since he left the hospital four years ago. But they hadn't forgotten his determination to recover, something that they say was evident from the outset.

Sharon Resmondo, who was a night nurse then, choked up a bit as she recalled those days.

"The beginning was very hard," she said. "But he rallied every day."

"I have children his age," critical care nurse Melanie Norris added. "It was his resolve: he was going to get through it. Your heart went out to him. He hasn't proven us wrong yet."

Hospital staffers remember lighter moments, too, particularly the unending stream of visitors, mostly his classmates, and their gentle bending of the rules to allow them to be there for their friend. His hospital room was rearranged to bring in a big-screen TV, and some friends even slept over.

Nurse Practitioner Sharon Resmondo, center, holds up her phone so that other medical staff who couldn't see Michael Doherty in person could visit with him in a video chat on Wednesday, December 9, 2020 at Lakeview Regional Medical Center near Covington. Doherty wanted to thank the medical staff that helped him during surgery and in his recovery following a spinal injury suffered during a high school football game in November 2016. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)

Dr. Marco Hidalgo, medical director of the hospital's trauma program, said there was a train of people bringing food just for the visitors.

"I kept asking, 'Don't these kids have to go to school?' There was never a day when there were not at least a dozen," Hidalgo said. "He had more visitors in a day than the whole hospital has now."

Because of COVID-19, he pointed out, such attention isn't possible.

Doherty, at the time a junior defensive back, was injured in what appeared to be a routine play in a November 2016 playoff game against Archbishop Shaw. But after the play, Doherty couldn't pick himself up.

Michael Doherty, center, is surrounded by some of the medical team that helped him during surgery and recovery at Lakeview Regional Medical Center near Covington back in November 2016 following a spinal injury he suffered at a high school football game. On Wednesday, December 9, 2020, Doherty drove to the hospital using a modified truck to thank the staff. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)

Dr. Justin Owen, a neurosurgeon, got the phone call from the football field that night about an injured player who couldn't feel his legs. While those on the scene were focused on his thoracic spine, Owen said he was much more concerned about his neck, and that is where his spinal cord was compressed, at the C5-6 vertebrae. Doctors were also worried about a possible clot in one of the arteries that supplies blood to the brain.

Owen and the others operated on Doherty deep into the next morning and the plan was to transfer him to New Orleans afterward. But Owen said the south shore hospital "got cold feet." So Lakeview reevaluated him and kept a very close eye on him, he said.

His caregivers agree that the presence of so many people was a key to Doherty's recovery, which wouldn't have been possible if he had been moved. "The fact that he was closer meant that family and friends could be there," Hidalgo said.

Doherty left Lakeview Regional to go the Shepherd Center in Atlanta, where he worked hard at rehabilitation, returning to St. Paul's in March of 2017 to finish his junior year. He has returned to the Shepherd Center since, and also works on his own.

He has some feeling in his legs and has regained enough arm movement to handle a cellphone, cups and the all-important hand controls for his truck.

"It gives me a lot of independence," he said. "I had to rely on other people for rides."

Michael Doherty visits with the medical team that helped him during surgery and recovery at Lakeview Regional Medical Center near Covington on Wednesday, December 9, 2020. In November 2016, Doherty suffered a spinal injury during a high school football game. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)

As for school, he jokingly told Owen, "It's fun, but the school part sucks." He's looking forward to life after college, when he hopes to have a career in sports administration.

His love of football hasn't diminished, and his on-campus job is working in the player personnel office for the LSU football program, which handles recruitment.

"It was a great year last year, then 2020 came," Doherty said with a smile.

But his biggest goal remains to walk again. Owen and Hidalgo believe he will.

"You're going to walk again, I know it's going to happen," Hidalgo told Doherty. The reason, he said, is Doherty's spirit. "I really would not tell that to a lot of patients."

The steering wheel on the modified truck that Michael Doherty drives. Doherty recently visited with the team at Lakeview Regional Medical Center near Covington that helped him during surgery and recovery following a spinal injury he suffered while playing high school football in November 2016. Doherty uses a wheelchair to get around but he and his doctors hope he'll be able to walk again in the future. (Photo by Chris Granger | The Times-Picayune | The New Orleans Advocate)

Owen pointed to advances in research, including stem cell therapy and robotics, and Doherty's youth. Statistically, those most likely to succeed are often athletes, he said, because they understand the demands that must be met to do something like winning a two-minute race.

For Doherty, the race is more of a marathon, but one he intends to win.

He found himself in a reflective mood after watching a football game at his alma mater before Thanksgiving, prompting him to make a rare post on social media. "Four years ago, I played my last football game and my life was forever changed," he wrote. "I miss playing football, and I wish I could play one more game."

But he also stressed the positives in his life. "I want to thank every doctor, nurse and therapist that has helped me along the way," he wrote. "I appreciate everything you had done for me. This journey will not stop until I reach my final goal of walking again."

"I wouldn't be where I am today without them."

Read more from the original source:
Four years after devastating spinal injury, former St. Paul's football player reunites with caregivers - NOLA.com

New Combination Therapy Tested By Children’s May Offer Hope For Leukemia Patients – WVXU

Cancer cells pose an uncanny ability to make new cells and dodge drugs, "somewhat like would-be robbers hacking the bank's alarm code," one doctor explains. But researchers at Cincinnati Children's Hospital Medical Center have figured out how cancer cells rewire themselves and, in turn, how to possibly overcome drug resistance.

This drug resistance may explain why some acute myeloid leukemia (AML) and other cancer patients suffer fatal relapses despite many improvements in leukemia outcomes over the years, according to a Children's news release.

"Overcoming resistance to therapy remains a holy grail of leukemia treatment," says Yi Zheng, Ph.D., director, experimental hematology and cancer biology at Cincinnati Children's. Zheng and his colleagues have now discovered a way to boost the effectiveness ofmTOR inhibitors, which prohibit unwanted cell proliferation.

"While the latest study is based on mouse models, building upon the findingspublished Dec. 21, 2020, in PNASeventually could improve outcomes for people with AML, and possibly other forms of cancer," a release says.

What Happens When Treatments Target mTOR?

"Using a novel mouse model, we have learned that deleting the mTOR gene prompts blood stem cells to multiply rapidly to open other pathways to continue producing new blood cells," says Zheng, the study's senior author. "We also found that leukemia cells use a similar response to continue multiplying despite mTOR-inhibiting treatments."

He says attacking mTOR essentially sets off alarms among hemopoietic stem cells (HSCs), which act like blood cell factories deep in bone marrow. Then the cells themselves produce a flood of new, re-wired blood cells. These re-wired stem cells, treated with mTOR inhibitors, can begin multiplying, rendering mTOR inhibitor drugs useless.

The co-authors say mTOR treatment resistance can be counteracted by inhibiting activity of the MNK, CDK9 or c-Myc genes. So-called BET inhibitors can act against c-Myc activity. Other inhibitors that are in clinical trials can act against CDK9.

Next Steps

Scientists at Cincinnati Childrens have already launched some of the research needed to prepare the combination therapies for in vivo test leading to human clinical trials, the news release says. That process will take time, but since mTOR inhibitors have been widely tested in clinical trials, investigators have a head start on exploring combination therapies.

Longer term, the findings may extend beyond AML, Zheng says, because mTOR has been a recognized target in most human cancers, including solid tumors like brain tumors.

Here is the original post:
New Combination Therapy Tested By Children's May Offer Hope For Leukemia Patients - WVXU

Ashley Cain says over 80,000 people registered for stem cell donation in 48 hours after appeal to save baby – The Sun

ASHLEY Cain has revealed more than 80,000 have people joined the stem cell register after he pleaded for the public's help to save his baby daughter's life.

Little Azaylia was diagnosed with one of the rarest forms of leukaemia, AML [Acute Myeloid Leukaemia] , last month and needs a stem cell transplant to beat the disease.

7

Ashley, 30, called upon his fans to help him and his partner Safiyya Vorajee find a donor - along with the charitable organisations DKMS and Anthony Nolan - for the four-month-old tot.

In a new interview, Ashley and Safiyya have spoken for the first time at their shock at the overwhelming amount of support they received and opened up about the turmoil they're going through as they watch their baby daughter fight for her life.

Former footballer Ashley said: "When Azaylia needed a donor the amount of people who came together straight away to order test kits, do the tests and then send them back, was crazy.

7

"The DKMS and Anthony Nolan probably get around 30,000 to 40,000 registers a year. We got 80,000 people in a single weekend.

"It's now topping 100,000. And not only are they helping Azaylia, they are helping the thousands of people who also need donors.

"Social media can be such a cruel and cynical place at times but this has made me realise how beautiful it can be and how beautiful the people using it can be.

"For that support we will be forever grateful."

Ashley and Safiyya are currently living in a hotel next to Birmingham Children's Hospital to ensure they can be with their daughter around the clock.

Because of Covid-19 restrictions the couple can not be with their baby daughter together so spend 24 hours a day with her on rotation so they can both spend equal amounts of time with her.

7

When they first discovered Azaylia was sick, Ashley said the couple were warned to expect the worst.

He explained: "When Azaylia first got diagnosed it looked really bleak.

"Me and you as normal people would have a white cell count of five. Someone with leukaemia, even an adult, would have a white cell count of 40.

"Azaylia had a white cell count of 200. Plus tumours in her lungs, kidneys and stomach.

"I am strong but having that news was something I never thought I would have to go through. It broke me. I was a broken man."

7

Azaylia has since undergone two rounds of chemotherapy and is responding well to treatment.

However she will need a life-saving transplant in order to beat the disease once and for all.

Ashley added: "Its very rare to have leukaemia in babys as young as Azaylia, she is the only baby on the ward.

7

"And she also has AML, the most aggressive type of leukaemia, which is even rarer.

"And what is even rarer again is the fact that she had tumours on her stomach, her lungs and her kidneys. And that her white blood cell count was so high.

"Realistically for her to have even got to this point is an absolute miracle."

Ashley and Safiyya also wanted to speak publicly to warn other parents about the signs to look out for after doctors repeatedly misdiagnosed Azaylia.

Ashley said: "We had back and forth to the doctors over the course of four weeks. She had cold type symptoms and we got told she had a blocked nose. At points we were pleading with the doctors to let us come in because we knew something wasnt right.

"Then we were told she had colic and then they told us she had constipation. We did all the things to treat that and then we noticed the mottling."

Going back to the beginning, Safiyya continued: There was an occasion four weeks after Azaylia was born when there was red spotting in her nappy.

7

I went to the doctors and they told me to keep an eye on it. Then a little while after she had a really bloated stomach. I called up the doctor and then I took them in for her first course of injections.

Prior to her having her six week injection the doctor gave her a once over. I told the doctor about her stomach and that her chest was really heavy, it sounded like her chest was rattling it was like she couldnt breathe properly.

Her eyes were gunking up too, to the point where they were really swollen. It was making her face then swollen.

The tummy was so hard, it was like a hard ball, obviously now that was all the tumours. They gave her laxatives to try and sort it out, they gave us colic mixture, they gave us a spray for her nose

To know a doctor has felt over all the symptoms that were there, and there were two-three-four-five doctors we saw. The doctor I sent the picture of the mottling to was an on call doctor and he was the one who said take her immediately to A and E.

7

The couple now credit Azaylia for giving them the strength to continue their appeal for donors.

Ashley added: We call Azaylia little lion, she has the face of an angel and the heart of a lion.

It is personally inspiring every day for us to see her sheer strength. Her waking up smiling every day, no matter what she is going through, gives us strength.

Exclusive

Exclusive

Exclusive

We also have to thank Birmingham Childrens hospital. We heard a lot about them before and everything we had heard was right.

From the nurses to the cleaners to the doctors, everyone goes the extra mile. They do incredible work but they also make you feel so at home.

Its those little touches and the extra effort they put into helping you which they dont get paid for. They all go the extra mile. To everyone on ward 18, they are just incredible.

If you want to help, you can join the register here.

Originally posted here:
Ashley Cain says over 80,000 people registered for stem cell donation in 48 hours after appeal to save baby - The Sun

The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 – Business Insider – Business Insider

MSPhotographic/Getty Images

Most kids with peanut allergies do not outgrow them. But, with a little help, some might be able to better tolerate accidental exposures.

In January, the Food and Drug Administration approved Palforzia, a new drug designed to help kids who are allergic to peanuts react better, if they are accidentally exposed.

"Because there is no cure, allergic individuals must strictly avoid exposure to prevent severe and potentially life-threatening reactions," Dr. Peter Marks, director of the FDA's Center for Biologics Evaluation and Research said at the time in a news release. "When used in conjunction with peanut avoidance, Palforzia provides an FDA-approved treatment option to help reduce the risk of these allergic reactions."

Palforzia is not designed to be administered during an allergic reaction, instead it works as an allergy exposure therapy: children ages 4 through 17 receive daily doses of peanut powder under clinical supervision, and slowly up-dose it over time.

In clinical trials, the strategy worked well, but not perfectly. When peanut-allergic kids were fed 600 milligrams of peanut protein, 67.2% of Palforzia recipients who'd been using the medication for six months tolerated it, while only 4% of the control group did.

The rest is here:
The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 - Business Insider - Business Insider

Startups are racing to reproduce breast milk in the lab – MIT Technology Review

Biomilq was on the brink of shuttering when Strickland and Egger were promised $3.5 million in funding from a group of investors led by Breakthrough Energy Ventures, which Bill Gates had established to back technologies that could reduce carbon emissions. Upending the formula industry held the promise of doing just that. As the spring of 2020 gave way to summer, the money arrived in Biomilqs bank account.

Biomilq is not the only company aiming to make a new kind of baby formula. Using a broadly similar approach, TurtleTree Labs in Singapore eventually hopes to replace all milk currently on the market, according to cofounder Max Rye. In addition to other projects, the company is working to create fortifiers that can be added to formula to duplicate the properties of breast milk. Some formulas are already fortified with proteins and carbohydrates derived synthetically or from cows milk. Another cofounder, Fengru Lin, explains that, in contrast to Biomilq, TurtleTree plans to work with the formula industry and hopes to get its products to market in 2021.

Meanwhile, Helaina, a company based in New York, will emulate breast milk through fermentation. Laura Katz, the companys founder, plans to use microbes to synthesize the milks constituent compoundsproteins, carbohydrates, and fatsand then recombine them into a nutritious liquid. Since similar processes have already won approval from the US Food and Drug Administration for products like Impossible Burgers, which are made from fermented soy protein, she hopes to face fewer regulatory hurdles than her competitors. Like Strickland and Egger, she is motivated by indignation at the lack of options for new parents.

I think the best thing we can do is support women to breastfeed, Katz says. But if thats impossible, mothers deserve something better than current infant formula. She adds, I see all this innovation happening in cell-based meat production for people who just want to eat a burger, but the products that we feed babies have stayed static over the past 20, 30 years.

None of these propositions will be scientifically simple, in part because relatively little is known about breast milk. Most studies of human mammary epithelial cells tend to focus on their role in breast cancer rather than milk production.

As for the milk itself, its a rich and bewildering stew of thousands of chemicals. We know nutritionally about the proteins, the carbohydrates, and the fat in there. We know about some particular bioactive molecules in there, like oligosaccharides [complex sugars that feed healthy bacteria in a babys gut], IgA [the main antibody found in breast milk], bile-salt-stimulated lipase [an enzyme that aids in the digestion of fats]these things that people always bring up as being good in breast milk, says Tarah Colaizy, the research director of the Human Milk Banking Association of North America, who also teaches at the University of Iowa. But, she notes, breast milk also contains short strands of RNA, whose presence was only discovered in 2010, and whose role in infant development is not yet well understood.

Original post:
Startups are racing to reproduce breast milk in the lab - MIT Technology Review

3-year-old patient successfully treated for rare fatal disease- familial Hemophagocytic lymphohistiocytosis (HLH) at Fortis Hospital Shalimar Bagh -…

New Delhi: Recently, a 3-year-old patient, Nashra Khan, was brought to Fortis Hospital Shalimar Bagh, where after a thorough medical evaluation she was diagnosed with hemophagocytic lymphohistiocutosis, a rarely occurring hereditary auto-immune condition with a five percent survival rate. A multidisciplinary approach was adopted to treat her, and the case was led by Dr Rahul Bhargava ( Director & Head, Blood Disorder, Hematology |Medical Oncology, Hematology & BMT) and Dr Amrita Chakrabarti (Associate Consultant, Hematology and Bone Marrow Transplant).

On 3-year-old patient successfully treated for rare fatal disease- familial Hemophagocytic lymphohistiocytosis (HLH) at Fortis Hospital Shalimar Baghresentation, the patient had a fever, was suffering from diarrhea, and abdominal swelling. Her medical history indicated that her elder siblings had also reported similar conditions, before passing away. She was evaluated on an urgent basis blood tests, scans, and a bone marrow test which confirmed the diagnosis of familial HLH. She was carrying a very rare mutation in her genes, STXBP2, which (helped confirm this rare genetic disease called Familial HLH).

Dr Rahul Bhargava (Director & Head, Blood Disorder, Hematology | Medical Oncology, Hematology & BMT) said, We commenced her treatment with chemotherapy an attempt to suppress her overactive, abnormal and self-harming immune system. We adopted the HLH protocol 94 and once the initiation phase was completed, we went ahead with a half-matched bone marrow transplant (also called Haploidentical stem cell transplant). The father donated his stem cells, which were collected, stored, and later transplanted into Nashra after treating her with Treosulphan, Fludarabine and TBI conditioning.

Dr Amrita Chakrabarti (Associate Consultant, Hematology and Bone Marrow Transplant) said, Nashra remained critically ill for about 3 months after her transplant. She developed a number of complications such as acute skin and gut graft Vs host disease a condition resulting in development of widespread nasty blisters all over the skin and within the linings of the food pipe, stomach and the intestines. She also developed cytomegalovirus infection- a viral infection causing malfunctioning of the bone marrow and the blood counts to go down. Posterior reversible encephalopathy syndrome was another complication that she developed, causing her to have recurrent seizure episodes.

Dr Bhargava added, We continued to do our best to save the child. She was continuously treated with steroids, immunomodulatory drugs, immunoglobulins, antibiotics, and repeated blood transfusions. Eventually, her overall condition started improving slowly and she was then able to sustain herself without needing blood transfusions. Her bone marrow transplant was a success as her chimerism reports showed a 100% healthy donor type of cells were now being made by her bone marrow. It has now been over a year and a half since her bone marrow transplant, and I am happy to say that Nashra has fully recovered.

Mr Mahipal Bhanot, Zonal Director, Fortis Hospital, Shalimar Bagh said, Fortis Hospital Shalimar Bagh approaches every case in a manner which is beneficial for the patient. Our doctors remain committed to treating every patient even amid the pandemic and we are truly proud of them. This case was extremely challenging, but our doctors ensure that the best possible outcome was achieved. I congratulate them for their commitment to world class patient care.

Familial or inherited HLH is an extremely rare disease passed down by the families due to certain genetic defects. It results in some of the immune system cells called T and NK cells becoming malfunctioning, resulting in their over activity leading to excessive inflammation and tissue destruction. As a result of this malfunction, the immune system begins to damage the patients own organs and tissues, such as the liver, brain, and bone marrow. When the bone marrow gets affected, blood production may be hampered and there may be a suppression of two or more cell components of the blood.

Read this article:
3-year-old patient successfully treated for rare fatal disease- familial Hemophagocytic lymphohistiocytosis (HLH) at Fortis Hospital Shalimar Bagh -...

Hand weakness: Causes, symptoms, treatment, and seeking help – Medical News Today

Hand weakness can occur due to a variety of conditions, such as carpal tunnel syndrome, arthritis, peripheral neuropathy, and ganglion cysts.

A weakened hand or grip can make everyday tasks much more difficult to complete.

In this article, we discuss some causes of hand weakness, the accompanying symptoms, and the treatment options available.

Ganglion cysts are fluid-filled sacs that typically form on or near a joint or tendon.

According to the American Academy of Orthopaedic Surgeons (AAOS), ganglion cysts are the most frequently forming lump in the hand. They often appear on the back of a persons wrist.

Although harmless, ganglion cysts can sometimes put pressure on the nerves, which can cause muscle weakness, tingling, and pain. Most of the time, these lumps are only a cosmetic issue, and they rarely cause sensory changes or weakness.

Learn more about ganglion cysts here.

Ganglion cysts do not typically require treatment. However, if the cyst is causing pain, a person can receive the following types of treatment:

A person may also take over-the-counter pain medication if the cyst is causing discomfort.

Carpal tunnel syndrome occurs when the carpal tunnel, which is a passageway in the wrist, or the tissues surrounding the flexor tendons swell. This in turn puts pressure on the median nerve.

This pressure can result in pain, tingling, and numbness in the hand.

According to the AAOS, carpal tunnel syndrome may occur due to different factors, such as repetitive hand use, pregnancy, and some health conditions.

Alongside hand weakness, other symptoms include:

A person may also find that they are dropping things due to hand weakness and numbness. This is a late-stage effect of carpal tunnel syndrome.

Usually, the tingling and pain are present for a long time and may become severe before weakness develops.

Learn more about carpal tunnel syndrome here.

Treatment options for carpal tunnel may include:

Learn more about natural and home remedies for carpal tunnel syndrome here.

Cubital tunnel syndrome occurs when the ulnar nerve, which passes through the inside of the elbow, becomes irritated, inflamed, swollen, or compressed.

Although cubital tunnel syndrome may cause pain in the elbow, most of the symptoms occur in the hand.

Symptoms may include:

Learn more about cubital tunnel syndrome here.

According to the AAOS, treatment options include:

Epicondylitis occurs due to damage to the tendons in the forearm. There are two types of epicondylitis: lateral and medial.

Medial epicondylitis, otherwise known as golfers elbow, occurs due to damage to the tendons that bend the wrist toward the palm.

Lateral epicondylitis, also known as tennis elbow, occurs due to damage to the tendons that bend the wrist away from the palm.

Some causes include playing tennis, carrying heavy objects, and frequently using hand tools.

Symptoms of epicondylitis include:

Learn more about lateral epicondylitis here.

Learn more about medial epicondylitis here.

Treatment starts with stopping the activity that caused the condition in the first place and avoiding activities that aggravate the condition.

Treatment options include:

Learn more about exercises for tennis elbow here.

A pinched nerve, or cervical radiculopathy, occurs when something presses against and irritates a nerve located in the neck.

This may stem from changes that occur in the spine as a person ages. It can also occur due to sudden injury that results in a herniated disk.

The pain typically originates in the neck and travels down a persons arm.

Other symptoms include:

Treatment for a pinched nerve includes:

Learn more about how to treat a pinched nerve here.

According to the AAOS, there are over 100 different types of arthritis. Osteoarthritis and rheumatoid arthritis are the most frequent.

Common symptoms of arthritis may include:

Learn more about arthritis in the hands here.

A person should contact their doctor about the best treatment options for them.

A doctor will determine the best treatment based on a persons individual circumstances.

Treatment options may include:

Sarcopenia is the loss of muscle mass. The condition causes weakness and loss of muscle functions, including strength in the hands. It can occur naturally as a person ages.

Other symptoms can include:

Learn more about sarcopenia here.

Treatment options focus on preventing and managing the condition through physical activity, such as resistance training. This can help improve strength and reduce muscle loss.

A person can also increase their protein intake. A 2020 article suggests consuming 2035 grams of protein per meal.

According to the National Institute of Neurological Disorders and Stroke (NINDS), peripheral neuropathy can develop due to conditions that involve damage to the peripheral nerves.

There are over 100 types of peripheral neuropathy, and the symptoms depend on the type of nerves affected.

Neuropathy that can affect the hands includes:

Learn more about peripheral neuropathy here.

If a doctor determines a person has peripheral neuropathy, they will recommend the person continue to treat the underlying condition. A person needs to follow all of the doctors recommendations and let them know if the treatment is not working.

To treat peripheral neuropathy directly, a doctor may recommend braces and splints, as well as pain relief medication.

Learn how to treat peripheral neuropathy naturally here.

Multiple sclerosis (MS) is a condition that affects the central nervous system.

Scientists do not exactly know what causes MS. They believe, however, that it is an autoimmune condition where the immune system attacks the myelin, which insulates the nerves.

According to the NINDS, most people with MS experience muscle weakness in their extremities. They may also experience numbness and prickling sensation.

There is currently no cure for MS. However, treatment typically involves medications and physical therapy.

Learn more about the treatment for MS here.

A stroke occurs as a result of a decrease or blockage in the brains blood supply or when a blood vessel in the brain bursts.

Strokes can cause numbness or weakness in the arm, face, or leg, particularly on one side of the body.

Other symptoms of a stroke include:

The treatment for a stroke depends on the type of stroke a person has experienced.

Learn more about the treatment options for a stroke here.

A person should seek emergency medical attention if they notice any symptoms of a stroke.

A person should consult their doctor if they have sudden weakness in one or both hands.

They should also contact a doctor if the treatment they are currently using is not working. A doctor may help determine a better course of treatment.

A doctor will need to perform a physical examination of the person and discuss their symptoms. They will also ask about other symptoms the person has experienced.

During the examination, the doctor may test a persons strength and pain level.

If needed, the doctor may order additional imaging tests to look at the joints. This may include an X-ray or MRI scan. A doctor can use this to diagnose conditions such as arthritis and assess the amount of damage to the joints.

Hand weakness can result from several different conditions, including a ganglion cyst, carpal tunnel syndrome, and cubital tunnel syndrome.

It can also be a part of many different health conditions that cause neuropathy.

A person will likely experience other symptoms, such as pain, swelling, or limited mobility of the hand or fingers.

A person should contact their doctor about all the symptoms they experience. A doctor can diagnose the issue and recommend treatments based on the underlying condition causing the weakness.

Follow this link:
Hand weakness: Causes, symptoms, treatment, and seeking help - Medical News Today

Gujarat Issues Health Advisory On Fungal Infection With "50% Mortality Rate" – NDTV

Gujarat health advisory lists SOPs against mucormycosis. Wearing masks is one of them.

The Gujarat health department has issued an advisory to doctors and health officials after some COVID-19 patients were recently found infected with mucormycosis, saying it a serious but rare fungal infection and has an overall "mortality rate of 50 per cent".

As per the advisory issued on Monday, mucormycosis infects people with weak immune system and having other existing illnesses.

The Gujarat health department said the advisory is being issued after some coronavirus patients in Ahmedabad and Rajkot were found infected with mucormycosis, which is "serious but rare infection caused by a group of molds called mucormycetes".

"It most commonly affects the sinuses or lungs after inhaling fungal spores from the air, or the skin after the fungus enters through a cut, burn or other type of skin injury. However, it can occur in any part of the body," said the advisory.

It said though the "overall mortality rate is around 50 per cent", early identification and treatment can help.

The advisory said people having diabetes or cancer, or those who underwent organ transplant, stem cell transplant or people having too much iron in the body are at a greater risk of contracting this infection.

The health department made it clear that mucormycosis "cannot spread between people or between people and animals".

"People get mucormycosis through contact with fungal spores in the environment," it said.

Enlisting some preventive measures, like wearing N95 masks, the advisory said these are recommendations and they "have not been proven to prevent mucormycosis".

Apart from wearing the N95 mask, people should avoid direct contact with lot of dust, wear shoes, long pants and gloves while handling soil or moss, and clean skin injuries well with soap and water, said the advisory.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

Read this article:
Gujarat Issues Health Advisory On Fungal Infection With "50% Mortality Rate" - NDTV

A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines – STAT

In an ideal world, a pandemic vaccine could be delivered in a single shot, so supplies could be stretched to cover a lot of people. It would trigger no side effect more significant than a sore arm. And it would be easy to ship and store.

Unfortunately, this is not an ideal world not yet, anyway.

For now, the good news is that the United States has two Covid-19 vaccines that have been shown to be highly effective.

advertisement

What follows is a head-to-head comparison of the ones developed by Pfizer and its partner, BioNTech, and by Moderna. Note that the chances of most individuals being able to pick one or the other are slim to none, especially in the initial rollout. The vaccine available is the one youll get.

The Pfizer emergency use authorization is for people aged 16 and older. Modernas is for people 18 and older, though the company has recently begun testing its vaccine in 12- to 17-year-olds.

advertisement

Both vaccines have shown astonishing and essentially equivalent degrees of efficacy, at least in the early stages after vaccination. How they stack up over the long term remains to be seen.

The Pfizer vaccine showed efficacy of 95% at preventing symptomatic Covid infection, measured starting from seven days after the second dose was administered. The vaccine appeared to be more or less equally protective across age groups and racial and ethnic groups.

The Moderna vaccine was 94.1% effective at preventing symptomatic Covid-19, measured starting from 14 days after the second dose. The vaccines efficacy appeared to be slightly lower in people 65 and older, but during a presentation to the Food and Drug Administrations advisory committee the company explained that the numbers could have been influenced by the fact there were few cases in that age group in the trial. The vaccine appeared to be equally effective across different ethnic and racial groups.

Both vaccines seemed to reduce the risk of severe Covid disease. Its not yet known if either prevents asymptomatic infection with the SARS-CoV-2 virus. Nor is it known if vaccinated people can transmit the virus if they do become infected but dont show symptoms.

Both the Moderna and the Pfizer/BioNTech vaccines require two shots: a priming dose, followed by a booster shot. The interval between Moderna doses is 28 days; for the Pfizer vaccine, its 21 days.

Each dose of Pfizers contains 30 micrograms of vaccine. Moderna went with a much larger dose of vaccine, 100 micrograms. It means it is using a little more than three times as much vaccine per person as Pfizer is. And yet, they arent getting better results.

In the vernacular of vaccinology, vaccines that trigger a range of transient side effects in a lot of recipients are known as reactogenic.

Both these vaccines in fact, most if not all the Covid-19 vaccines that have reported data so far fall into the reactogenic category. The Advisory Committee on Immunization Practices, an expert panel that helps the Centers for Disease Control and Prevention set vaccination policies, has advised hospitals they may want to stagger vaccinations among staff for instance, dont vaccinate all the emergency room staff at the same time in case some feel too unwell to work the day after being vaccinated.

The most common side effects are injection site pain, fatigue, headache, muscle pain, and joint pain. Some people in the clinical trials have reported fever. Side effects are more common after the second dose; younger adults, who have more robust immune systems, reported more side effects than older adults.

To be clear: These side effects are a sign of an immune system kicking into gear. They do not signal that the vaccine is unsafe. To date there are no serious, long-term side effects associated with receipt of these vaccines, which will be closely monitored as their use expands.

There have been a handful of reports of people having allergic reactions to the Pfizer vaccine since its rollout began. Those reactions anaphylaxis or a less severe allergic reaction were not seen in the clinical trials. It remains to be seen if similar events will be seen with the Moderna vaccine.

Neither of the vaccines has been tested in these two groups.

Moderna has completed animal studies the FDA demanded of manufacturers; these studies look for evidence that the vaccine might harm the pregnancy or the developing fetus. The company said it saw no such signals.

Pfizer has only interim data from its animal studies, but said it saw no concerning signs either.

The authorizations for both vaccines state there are not enough data to gauge whether they are safe for pregnant or lactating people. FDAs Peter Marks, director of the Center for Biologics Evaluation and Research, said Friday that those who are pregnant should choose whether to be vaccinated after discussing the risks and benefits with their physicians.

Both of these vaccines require an elaborate cold chain, the term used to describe the conditions under which vaccines must be stored during distribution and when they are in the doctors offices, pharmacies, or public health clinics where theyll be administered.

But the Moderna vaccine will be far easier to use than Pfizers. For starters, Modernas must be shipped at -4 Fahrenheit; Pfizers must be shipped and stored at -94 Fahrenheit. The former is the temperature of a regular refrigerator freezer; the latter requires special ultra-cold freezers that need to be topped up with dry ice every five days. Doctors offices do not have ultracold freezers; neighborhood pharmacies dont either.

After thawing, a vial of the Pfizer vaccine must be used within five days; Modernas is stable at fridge temperature for 30 days and at room temperature for 12 hours.

The ultracold storage requirement is not the only challenging aspect of the Pfizer vaccine. The minimum amount of vaccine a location can order is 975 doses. A large teaching hospital might need several of those. But there are plenty of places across the country that dont need 975 doses to vaccinate the people currently eligible for vaccination health workers and nursing home residents. This is the vaccine that needs to be kept at -94 F. The minimum order size will limit the locations in which this vaccine can be used.

The Moderna vaccines minimum order is 100 doses, a much more manageable number.

The Pfizer vaccine is shipped in five-dose vials; Modernas vaccine is shipped in 10-dose vials.

Figuring out how long the protection provided by either of these vaccines will last will take time. Its going to involve periodic blood draws from some volunteers to see what their antibody levels look like, though a decline in antibody levels doesnt necessarily equate to loss of protection.

But a large part of this work will involve watching for reports that people who were immunized are starting to contract Covid in larger numbers, a development that would probably lead to recommendations to give people booster shots at some yet-to-be-determined interval.

Senior Writer, Infectious Disease

Helen covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development.

Trending

Let the ultra-rich and influential skip the line for

Let the ultra-rich and influential skip the line for Covid-19 vaccines? Hear me out

The story of mRNA: How a once-dismissed idea became

The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine

Watch: What to expect when youre injected: Vaccine side

Watch: What to expect when youre injected: Vaccine side effects explained

Recommended

Let the ultra-rich and influential skip the line for

Let the ultra-rich and influential skip the line for Covid-19 vaccines? Hear me out

Beware the danger of vaccine euphoria

Beware the danger of vaccine euphoria

3 lessons from Stanfords Covid-19 vaccine algorithm debacle

3 lessons from Stanfords Covid-19 vaccine algorithm debacle

See the article here:
A side-by-side comparison of the Pfizer/BioNTech and Moderna vaccines - STAT